Published in BMC Infect Dis on March 11, 2011
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis (2013) 0.89
Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med (2014) 0.88
Oral care may reduce pneumonia in the tube-fed elderly: a preliminary study. Dysphagia (2014) 0.83
Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study. PLoS One (2015) 0.82
Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review. BMC Infect Dis (2015) 0.82
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score. Antimicrob Agents Chemother (2016) 0.77
Clinical and radiological characteristics of 2009 H1N1 influenza associated pneumonia in young male adults. Yonsei Med J (2013) 0.77
Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department. BMC Infect Dis (2014) 0.77
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia. Adv Ther (2016) 0.75
Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia. Korean J Intern Med (2016) 0.75
I-ROAD could be efficient in predicting severity of community-acquired pneumonia or healthcare-associated pneumonia. Singapore Med J (2014) 0.75
Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia. BMC Infect Dis (2017) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev (2001) 15.81
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med (2002) 8.67
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest (2005) 5.91
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis (2000) 4.01
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis (2010) 3.23
Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest (2008) 2.83
Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med (2005) 2.82
Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med (2007) 2.69
Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med (1998) 2.62
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med (1999) 2.55
Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
Nursing home-acquired pneumonia. Clin Infect Dis (2002) 1.78
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58
Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med (1998) 1.54
Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest (2009) 1.22
Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis (2009) 1.21
Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med (2004) 1.15
Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology (2008) 1.11
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02
Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med (2010) 1.01
Markers of treatment failure in hospitalised community acquired pneumonia. Thorax (2008) 1.00
Making sense of scoring systems in community acquired pneumonia. Respirology (2009) 0.89
Nursing home-acquired pneumonia: avoiding the hospital. J Am Geriatr Soc (1997) 0.81
Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med (2012) 6.73
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib. J Clin Oncol (2007) 3.70
Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.92
Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med (2012) 2.92
Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med (2005) 2.75
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2010) 2.04
Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82
Pulmonary inflammatory pseudotumor--a report of 28 cases. Korean J Intern Med (2002) 1.66
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2013) 1.62
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer (2007) 1.49
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer (2011) 1.49
Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia. Respir Med (2012) 1.48
The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci (2006) 1.44
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun (2004) 1.41
A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet (2003) 1.40
High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. Clin Cancer Res (2012) 1.39
Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients. J Infect (2011) 1.33
Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD (2013) 1.32
Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis (2011) 1.30
Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis (2012) 1.28
Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer (2007) 1.26
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Exp Ther Med (2011) 1.26
Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation. Am J Respir Cell Mol Biol (2011) 1.23
The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci (2011) 1.22
Retracted Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J (2012) 1.20
Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg (2004) 1.20
Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis (2010) 1.17
Risk factors and prognosis of pulmonary complications after endoscopic submucosal dissection for gastric neoplasia. Dig Dis Sci (2012) 1.16
Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg (2009) 1.15
Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study. Respir Med (2011) 1.14
An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care (2013) 1.14
Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol (2009) 1.11
High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. Clin Cancer Res (2009) 1.10
The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. Int J Chron Obstruct Pulmon Dis (2013) 1.07
Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. Cancer (2007) 1.05
Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int (2010) 1.05
The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis. Clin Infect Dis (2005) 1.04
Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol (2009) 1.03
Lung cancer in never smokers: change of a mindset in the molecular era. Lung Cancer (2011) 1.02
Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis (2010) 1.02
Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism. Yonsei Med J (2004) 1.01
A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. Lung Cancer (2010) 0.99
Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis (2009) 0.98
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J (2012) 0.98
A case of melioidosis presenting as migrating pulmonary infiltration: the first case in Korea. J Korean Med Sci (2005) 0.97
Urine Cotinine for Assessing Tobacco Smoke Exposure in Korean: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES). Tuberc Respir Dis (Seoul) (2012) 0.95
A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features. Oncol Rep (2008) 0.95
A feasibility study of adenosine triphosphate-based chemotherapy response assay (ATP-CRA) as a chemosensitivity test for lung cancer. Cancer Res Treat (2005) 0.95